Custom service

Peptide Drug Gene Construction and Expression Platform

Construct and express genes for peptide-drug screening scaffolds

Turnaround: 4–8 weeksTypical scale: 10^2 – 10^9 members by formatChemistry options: gene synthesis and vector design; expression construct optimization; display-format compatibility

Teams come to this service when they need to construct and express genes for peptide-drug screening scaffolds. We typically start from gene synthesis and vector design, add expression construct optimization where the application demands it, and close the loop with display-format compatibility so the final expression constructs and validated expression data behaves consistently across lots.

Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 4–8 weeks timeline holds in practice.

Display-library gene preparation

Recombinant scaffold supply for screening

GMP gene-drug product

Targets with no assayable readout and no purified protein available

Screening programmes close with a data package: primary screen statistics, confirmation data for each hit, counterscreen results and resynthesized material. Library lots ship with composition QC — representation and identity checks by LC-MS or NGS as the format requires.

Service Highlights

  • Gene synthesis and vector design as the default route, with expression construct optimization held as a proven fallback
  • Display-format compatibility worked into the design where the application requires it
  • Every reported hit is confirmed by independent resynthesis and re-testing before it reaches you
  • Analytical confirmation of every intermediate before the final release
  • Library integrity (composition, representation) is measured, not assumed, before screening begins
  • Expression constructs and validated expression data delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Library design

    Diversity, degeneracy and deconvolution strategy for Peptide Drug Gene Construction and Expression Platform are fixed in a design document.

  2. Library synthesis or construction

    The library is built with gene synthesis and vector design and its composition is QC'd before screening.

  3. Primary screening

    Screening runs with expression construct optimization, with controls and statistics defined in advance.

  4. Hit deconvolution

    Hits are identified and ranked; counterscreens remove non-specific and promiscuous binders.

  5. Hit confirmation

    Every hit is resynthesized and re-tested; only reproducible hits advance.

  6. Hit delivery

    Confirmed hits and Expression constructs and validated expression data are delivered with the full screening data package.

Specifications & timeline

Turnaround
4–8 weeks
Typical scale
10^2 – 10^9 members by format
Chemistry options
gene synthesis and vector design; expression construct optimization; display-format compatibility
Deliverable
Expression constructs and validated expression data
QC package
Library composition QC, screening raw data, hit confirmation package
Shipping
Ambient (plates, beads) or dry ice (display libraries)

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.